Overexpression of the mitotic spindle assembly checkpoint genes hBUB1, hBUBR1 and hMAD2 in thyroid carcinomas with aggressive nature
- PMID: 18383837
Overexpression of the mitotic spindle assembly checkpoint genes hBUB1, hBUBR1 and hMAD2 in thyroid carcinomas with aggressive nature
Abstract
Background: The mitotic spindle assembly checkpoint (MSAC) genes are responsible for preventing chromosome missegregation. MSAC gene expressions have been reported to be associated with tumor cell proliferation or unfavorable cancer behavior. The present study was conducted to preliminary investigate the MSAC gene expressions in thyroid neoplasms.
Materials and methods: Expression levels of MSAC genes (hBUB1, hBUBR1, hBUB3 and hMAD2) were evaluated in 9 follicular thyroid adenomas (FAs), 9 follicular thyroid carcinomas (FTCs), 21 papillary thyroid carcinomas (PTCs), 5 anaplastic (undifferentiated) thyroid carcinomas (ATCs) and 3 adjacent normal thyroid tissues (NTs) by real-time quantitative RT-PCR. These gene expressions were compared between undifferentiated thyroid carcinomas (ATCs) and differentiated thyroid carcinomas (DTCs) and between advanced DTCs and non-advanced DTCs. DTCs included PTCs and FTCs. Advanced DTCs were defined as carcinoma with aggressive nature such as extrathyroid extension, distant metastasis, recurrence or death from the disease.
Results: MSAC gene expressions varied in different thyroid tumors and fell in the order of ATC, DTC (PTC and FTC), FA and NT Carcinomas had higher expression compared to adenoma or normal tissue. hBUB1, hBUBR1 and hMAD2 expressions in ATCs were significantly higher than those in DTCs (p<0.005). hBUBR1 and hMAD2 expressions in advanced DTCs were significantly higher than those in non-advanced DTCs (p<0.05).
Conclusion: The MSAC genes were overexpressed in thyroid carcinomas with aggressive nature. Further studies are required to clarify the relationship between the MSAC gene expressions and thyroid cancer behavior.
Similar articles
-
Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival.Cancer Res. 2002 Jan 1;62(1):13-7. Cancer Res. 2002. PMID: 11782350
-
Silencing of the maspin gene by promoter hypermethylation in thyroid cancer.Int J Mol Med. 2003 Oct;12(4):479-84. Int J Mol Med. 2003. PMID: 12964023
-
Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer--association with tumour cell proliferation.J Pathol. 2003 May;200(1):16-22. doi: 10.1002/path.1324. J Pathol. 2003. PMID: 12692836
-
Genetic mutations in thyroid carcinoma.Minerva Endocrinol. 2009 Mar;34(1):11-28. Minerva Endocrinol. 2009. PMID: 19209125 Review.
-
Clinical impact of molecular analysis on thyroid cancer management.Surg Oncol Clin N Am. 2008 Jan;17(1):1-35, vii. doi: 10.1016/j.soc.2007.10.013. Surg Oncol Clin N Am. 2008. PMID: 18177798 Review.
Cited by
-
Mitotic chromosomal instability and cancer: mouse modelling of the human disease.Nat Rev Cancer. 2010 Feb;10(2):102-15. doi: 10.1038/nrc2781. Nat Rev Cancer. 2010. PMID: 20094045 Free PMC article. Review.
-
Aneuploidy: Cancer strength or vulnerability?Int J Cancer. 2019 Jan 1;144(1):8-25. doi: 10.1002/ijc.31718. Epub 2018 Oct 31. Int J Cancer. 2019. PMID: 29981145 Free PMC article. Review.
-
Gene expression profiling associated with the progression to poorly differentiated thyroid carcinomas.Br J Cancer. 2009 Nov 17;101(10):1782-91. doi: 10.1038/sj.bjc.6605340. Epub 2009 Oct 6. Br J Cancer. 2009. PMID: 19809427 Free PMC article.
-
The HuR CMLD-2 inhibitor exhibits antitumor effects via MAD2 downregulation in thyroid cancer cells.Sci Rep. 2019 May 14;9(1):7374. doi: 10.1038/s41598-019-43894-0. Sci Rep. 2019. PMID: 31089242 Free PMC article.
-
Predictive and prognostic values of BubR1 and synuclein-gamma expression in breast cancer.Int J Clin Exp Pathol. 2015 May 1;8(5):5345-53. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26191236 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous